• Publications
  • Influence
Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up.
BACKGROUND Lanthanum carbonate (LC) has been proposed as a new phosphate binder. Presented here are the results from one centre that participated in a multicentre trial to assess the effect ofExpand
  • 139
  • 2
Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.
BACKGROUND The existence of adynamic bone disease (ABD) as most prevalent form of renal osteodystrophy in recent years and its reduced ability to handle an exogenous calcium load has implied a higherExpand
  • 50
  • 2
Acquired Renal Cystic Disease and Tumor Markers in Chronic Hemodialysis Patients
Acquired renal cystic disease (ARCD) is a well documented complication of end-stage renal disease, and it has been related to the duration of dialysis therapy. The association of this condition withExpand
  • 17
  • 1
Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients.
Among non-traditional cardiovascular risk factors both malnutrition and inflammation appear to be strong predictors of mortality and morbidity in haemodialysis (HD) patients. Our study objective wasExpand
  • 16
  • 1
  • PDF
Brain Natriuretic Peptide between Traditional and Nontraditional Risk Factors in Hemodialysis Patients: Analysis of Cardiovascular Mortality in a Two-Year Follow-Up
Background: The ability of brain natriuretic peptide (BNP) together with other traditional and nontraditional risk factors to predict cardiovascular (CV) mortality in hemodialysis (HD) patients hasExpand
  • 5
Effect of nephrology referral on the initiation of haemodyalisis and mortality in ESRD patients.
Late nephrology referral of patients with chronic kidney disease (CKD) has been suggested as increasing mortality after the initiation of dialysis. The aim of this study was to assess the impact ofExpand
  • 9
  • PDF
Long-Term follow up of Sustained Viral Response after Treatment of Hepatitis C with Pegylated Interferon α-2a in Hemodialysis Patients
Purpose The aim of this study was to evaluate the persistence of sustained viral response after treatment of hepatitis C with pegylated interferon α-2a in hemodialysis patients. Methods 14Expand
  • 11
Survival of patients on maintenance haemodialysis over a twenty-year period.
Patient survival is a key index of the overall adequacy of treatment in most chronic diseases. Analyses of survival of patients undergoing haemodialysis is very important, as it may offer clues andExpand
  • 14
  • PDF
Patterns of viraemia in haemodialysis patients with hepatitis C.
Clinical features, aminotransferases levels, and antibody to HCV have only limited correlation with the activity of liver disease and cannot accurately predict persistence versus eradication of theExpand
  • 4
  • PDF
Factors associated with various arterial calcifications in haemodialysis patients.
BACKGROUND Haemodialysis (HD) patients are at increased risk of the development of arterial intimal (AIC) and medial calcification (AMC). The aim of our study was to analyze the association betweenExpand
  • 5
  • PDF